FDA Orange Book

Generic for Latisse

Latisse contains bimatoprost. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

Yes. The generic name for Latisse is bimatoprost. 2 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AT.

Run it in Rivvi

Map Latisse and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Latisse products in the Orange Book

Latisse products and approved generics
Form and route	Strength	Brand status	Brand TE	Active generics	Generic TE codes
solution/drops, topical	0.03%	Marketed (Rx)	AT	2	AT

NDA 022369, held by ABBVIE INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Approved generic bimatoprost

Approved generic versions of Latisse
Company	ANDA	TE code	Approved	Strengths
SANDOZ INC	202719	AT (A-rated, therapeutically equivalent)	April 19, 2016	0.03%
ALEMBIC PHARMACEUTICALS LTD	210515	AT (A-rated, therapeutically equivalent)	January 21, 2020	0.03%

Latisse NDC codes

0023-3616

Questions

Is there a generic for Latisse?

Yes. The generic name for Latisse is bimatoprost. 2 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AT.

What is the generic name for Latisse?

The active ingredient in Latisse is bimatoprost, per the FDA Orange Book.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.